ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,081, issued on May 12, was assigned to The Trustees of the University of Pennsylvania (Philadelphia).

"Tn-MUC1 chimeric antigen receptor (CAR) T cell therapy" was invented by Avery D. Posey (Philadelphia) and Carl H. June (Merion Station, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Various TnMUC1-specific chimeric antigen receptors (CARs), nucleic acids encoding the same, and methods of using the same, are provided. Compositions and methods comprising a TnMUC1-specific CAR for treating MUC1-associated cancer in a subject in need thereof are provided."

The patent was filed on July 8, 2021, under Application No. 17/370,655.

*For further inform...